Inventor · disambiguated record
Charles Bosworth
Also filed as: BOSWORTH CHARLES · BOSWORTH CHARLES F · BOSWORTH CHARLES FLOYD
12 granted patents·18 pending applications·90 citations·filing 2007–2025
88Inventor score
Files withAZURA OPHTHALMICS LTD21CS PHARMACEUTICALS LTD3OHIO STATE INNOVATION FOUNDATION2PFIZER2ALLERGAN INC1
Top patents by PatentIndex Score
30 records- 0195US11324775B2Compositions and methods for the treatment of contact lens discomfortAZURA OPHTHALMICS LTD·Filed 2021·Granted May 10, 2022·8 cites·20 claims
- 0294US10875845B2Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2020·Granted Dec 29, 2020·4 cites·20 claims
- 0393US11517586B2Instructions for composition and sensitivityAZURA OPHTHALMICS LTD·Filed 2021·Granted Dec 6, 2022·2 cites·19 claims
- 0488US12083147B2Compositions and methods for the treatment of contact lens discomfortAZURA OPHTHALMICS LTD·Filed 2022·Granted Sep 10, 2024·1 cites·20 claims
- 0588US8909327B1Instrument and method for diagnosing dry eye in a patientBOSWORTH CHARLES·Filed 2011·Granted Dec 9, 2014·71 cites·18 claims
- 0686US11459351B1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2021·Granted Oct 4, 2022·1 cites·16 claims
- 0784US11634411B2Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2020·Granted Apr 25, 2023·1 cites·1 claims
- 0879US2025099500A1Compositions and methods for the treatment of contact lens discomfortAZURA OPHTHALMICS LTD·Filed 2024·Application pending·0 cites
- 0978US2025042931A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2024·Application pending·0 cites
- 1074US7622475B2EP2 agonistsPFIZER·Filed 2007·Granted Nov 24, 2009·2 cites·7 claims
- 1174US2023357207A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2023·Application pending·0 cites
- 1274US2023346832A1Instructions for composition and sensitivityAZURA OPHTHALMICS LTD·Filed 2022·Application pending·0 cites
- 1373US11969212B2Methods and apparatus for detecting a presence and severity of a cataract in ambient lightingOHIO STATE INNOVATION FOUNDATION·Filed 2023·Granted Apr 30, 2024·0 cites·20 claims
- 1472US12350277B2Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surfaceCS PHARMACEUTICALS LTD·Filed 2023·Granted Jul 8, 2025·0 cites·24 claims
- 1572US2022409657A1Instructions for composition and sensitivityAZURA OPHTHALMICS LTD·Filed 2022·Application pending·0 cites
- 1672US2023348517A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2023·Application pending·0 cites
- 1771US2022332749A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2022·Application pending·0 cites
- 1869US11643429B2Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2021·Granted May 9, 2023·0 cites·20 claims
- 1964US2025295672A1Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surfaceCS PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 2064US2025262331A1Composition and methods for improving signs and symptoms of ocular disordersAZURA OPHTHALMICS LTD·Filed 2025·Application pending·0 cites
- 2160US2022305052A1Metered dose for disorders in or around the eyeAZURA OPHTHALMICS LTD·Filed 2022·Application pending·0 cites
- 2259US2022323487A1Metered dose for demodex and disorders related theretoAZURA OPHTHALMICS LTD·Filed 2022·Application pending·0 cites
- 2358US2010105905A1EP2 AgonistsPFIZER·Filed 2009·Application pending·0 cites
- 2457US2024285679A1Compositions and methods for vision improvementAZURA OPHTHALMICS LTD·Filed 2022·Application pending·0 cites
- 2557US2021196119A1Methods and apparatus for detecting a presence and severity of a cataract in ambient lightingOHIO STATE INNOVATION FOUNDATION·Filed 2019·Application pending·0 cites
- 2656US2024158375A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2021·Application pending·0 cites
- 2754US2023399317A1Compounds and methods for the treatment of ocular disordersAZURA OPHTHALMICS LTD·Filed 2021·Application pending·0 cites
- 2850US2023000675A1Device for administering drug to eyelidAZURA OPHTHALMICS LTD·Filed 2022·Application pending·0 cites
- 2947US11759472B2Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surfaceCS PHARMACEUTICALS LTD·Filed 2018·Granted Sep 19, 2023·0 cites·12 claims
- 3041US2019000808A1Composition and methods for the treatment of blephopharoptosisALLERGAN INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charles Bosworth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →